Myasthenia gravis (MG) in children and adolescents to age 18 -- juvenile MG -- includes clinically significant developmental ...

In this interview, Richard J. Nowak, MD, MS, principal investigator of the MINT trial of inebilizumab for generalized myasthenia gravis (gMG), discusses the trial’s key findings, including significant ...

ImmunAbs Inc., a clinical-stage biotech specializing in developing antibody therapeutics, today announced that the U.S. Food and Drug Administration has cleared its Investigational New Drug (IND ...

Need to Know He spotted weight-loss drugs and AI before they became hot. Here’s this investor’s next big idea. Citrini Research’s James van Geelen sees future robots cleaning your house ...

Evidence-based recommendations on efgartigimod (Vyvgart) for treating antibody-positive generalised myasthenia gravis in adults.. Last reviewed: 04 June 2025 Next review: This guidance will be ...

DNA floating in the air tracks wildlife, viruses -- even drugs. ScienceDaily . Retrieved June 20, 2025 from www.sciencedaily.com / releases / 2025 / 06 / 250603114822.htm ...

Between 1995 and 2021 private money spent on Alzheimer’s research came to $42.5bn, but more than 140 trials failed to yield a single drug capable of slowing the disease. Yet the tide may be turning.

SEOUL, South Korea I June 02, 2025 I ImmunAbs Inc., a clinical-stage biotech specializing in developing antibody therapeutics, today announced that the U.S. Food and Drug Administration has cleared ...

The Drug Enforcement Administration has arrested four Los Angeles County men who allegedly trafficked "vast quantities" of illegal drugs, including methamphetamine, cocaine and fentanyl. The men ...

Myasthenia gravis (MG) should be classified according to antibody status (acetylcholine, MuSK, LRP4, titin), thymus (hyperplasia, neoplasia, atrophy), age at debut (< or >50 years), symptom ...

Regeneron said on Monday its experimental drug helped patients preserve up to 51% of lean mass and lose more fat when used in combination with Novo Nordisk's popular obesity drug Wegovy in a mid ...

Exercise may significantly reduce the risk of colon cancer returning in patients after treatment, a new study has found. The late-phase trial, published Sunday in the New England Journal of ...